Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Collado

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Free Radical Biology & Medicine|October 16, 2007
Cytoprotective properties of alpha-tocopherol are related to gene regulation in cultured D-galactosamine-treated human hepatocytesRaul González, Juan Antonio Collado, Sandra Nell, et al.
Clinical and Experimental Rheumatology|June 23, 2021
Dietary habits in patients with fibromyalgia: a cross-sectional studyMiriam Almirall, Sergio H Martínez-Mateu, Cayetano Alegre, et al.
Journal of the International AIDS Society|November 14, 2014
Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic StudyKarin Neukam, Nuria Espinosa, Dolores Merino, et al.
Journal of Hepatology|March 12, 2019
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapyJuan Macías, Luis E Morano, Francisco Téllez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2009
Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppressionJosé A Mira, Alicia Gutiérrez-Valencia, Ignacio de los Santos Gil, et al.
HIV Clinical Trials|June 11, 2017
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort studyKarin Neukam, Luis E Morano-Amado, Antonio Rivero-Juárez, et al.
Antiviral Therapy|February 5, 2008
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patientsJosé A Mira, Luis F López-Cortés, Dolores Merino, et al.
Medicina Clinica|July 31, 2009
[Diagnosis and treatment of the neuropathic pain]Antonio Martínez-Salio, Agustín Gómez De la Cámara, María Victoria Ribera Canudas, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2007
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patientsJuan A Pineda, José A Mira, Ignacio de los Santos Gil, et al.
Reumatologia Clinica|October 15, 2021
Recommendations by the Spanish Society of Rheumatology on Fibromyalgia. Part 1: Diagnosis and treatmentJavier Rivera Redondo, Petra Díaz Del Campo Fontecha, Cayetano Alegre de Miquel, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Free Radical Biology & Medicine|October 16, 2007
Cytoprotective properties of alpha-tocopherol are related to gene regulation in cultured D-galactosamine-treated human hepatocytesRaul González, Juan Antonio Collado, Sandra Nell, et al.
Clinical and Experimental Rheumatology|June 23, 2021
Dietary habits in patients with fibromyalgia: a cross-sectional studyMiriam Almirall, Sergio H Martínez-Mateu, Cayetano Alegre, et al.
Journal of the International AIDS Society|November 14, 2014
Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic StudyKarin Neukam, Nuria Espinosa, Dolores Merino, et al.
Journal of Hepatology|March 12, 2019
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapyJuan Macías, Luis E Morano, Francisco Téllez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2009
Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppressionJosé A Mira, Alicia Gutiérrez-Valencia, Ignacio de los Santos Gil, et al.
HIV Clinical Trials|June 11, 2017
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort studyKarin Neukam, Luis E Morano-Amado, Antonio Rivero-Juárez, et al.
Antiviral Therapy|February 5, 2008
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patientsJosé A Mira, Luis F López-Cortés, Dolores Merino, et al.
Medicina Clinica|July 31, 2009
[Diagnosis and treatment of the neuropathic pain]Antonio Martínez-Salio, Agustín Gómez De la Cámara, María Victoria Ribera Canudas, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2007
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patientsJuan A Pineda, José A Mira, Ignacio de los Santos Gil, et al.
Reumatologia Clinica|October 15, 2021
Recommendations by the Spanish Society of Rheumatology on Fibromyalgia. Part 1: Diagnosis and treatmentJavier Rivera Redondo, Petra Díaz Del Campo Fontecha, Cayetano Alegre de Miquel, et al.
Pageof 8